| 000 | 01411 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514024141.0 | ||
| 264 | 0 | _c20020619 | |
| 008 | 200206s 0 0 chi d | ||
| 022 | _a1007-3418 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQian, Jun | |
| 245 | 0 | 0 |
_a[Arsenic trioxide for the treatment of medium and advanced primary liver cancer]. _h[electronic resource] |
| 260 |
_bZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _cFeb 2002 |
||
| 300 |
_a63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xadverse effects |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxides _xadverse effects |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aQin, Shukui | |
| 700 | 1 | _aHe, Zeming | |
| 700 | 1 | _aWang, Lin | |
| 700 | 1 | _aChen, Yingxia | |
| 700 | 1 | _aShao, Zhijian | |
| 700 | 1 | _aLiu, Xiufeng | |
| 773 | 0 |
_tZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _gvol. 10 _gno. 1 _gp. 63 |
|
| 999 |
_c11764716 _d11764716 |
||